T1	Participants 31 66	aneurysmal subarachnoid hemorrhage:
T2	Participants 166 228	patients with acute nontraumatic subarachnoid hemorrhage (SAH)
T3	Participants 451 471	randomized SAH trial
T4	Participants 690 707	ruptured aneurysm
T5	Participants 805 900	42 patients participating in the enoxaparin trial for acute aneurysmal SAH at four time points:
T6	Participants 1577 1592	severity of SAH
T7	Participants 1804 1830	ischemic deficit after SAH
T8	Participants 263 287	delayed ischemic deficit
T9	Participants 575 578	SAH
